COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,552 Articles (22,881 medRxiv, 8,671 bioRxiv)

Most recent first Previous |  Page 3155: Articles 31541-31550  | Next

Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China
Shen, M., Peng, Z., Xiao, Y., Zhang, L.
10.1101/2020.01.23.916726 — Posted: 2020-01-25
2019-20 Wuhan coronavirus outbreak: Intense surveillance is vital for preventing sustained transmission in new locations
Thompson, R. N.
10.1101/2020.01.24.919159 — Posted: 2020-01-25
Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions
Read, J. M., Bridgen, J. R., Cummings, D. A., Ho, A., Jewell, C. P.
10.1101/2020.01.23.20018549 — Posted: 2020-01-24 Discussion: Onsite | Offsite
Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm
Zhu, H., Guo, Q., Li, M., Wang, C., Fang, Z., Wang, P., Tan, J., Wu, S., Xiao, Y.
10.1101/2020.01.21.914044 — Posted: 2020-01-24 Discussion: Onsite
Pattern of early human-to-human transmission of Wuhan 2019-nCoV
Riou, J., Althaus, C. L.
10.1101/2020.01.23.917351 — Posted: 2020-01-24 Discussion: Onsite
Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak
Zhao, S., Ran, J., MUSA, S. S., Yang, G., Lou, Y., Gao, D., Yang, L., He, D.
10.1101/2020.01.23.916395 — Posted: 2020-01-24 Discussion: Onsite
The 2019-new Coronavirus epidemic: evidence for virus evolution
Benvenuto, D., Giovanetti, M., Ciccozzi, A., Spoto, S., Angeletti, S., Ciccozzi, M.
10.1101/2020.01.24.915157 — Posted: 2020-01-24 Discussion: Offsite
Novel ionophores active against La Crosse virus identified through rapid antiviral screening
Sandler, Z. J., Vu, M. N., Menachery, V. D., Mounce, B. C.
10.1101/2020.01.21.914929 — Posted: 2020-01-23
Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin
Shi, Z.-L., Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., Zheng, X.-S., Zhao, K., Chen, Q.-J., Deng, F., Liu, L.-L., Yan, B., Zhan, F.-X., Wang, Y.-Y., Xiao, G.
10.1101/2020.01.22.914952 — Posted: 2020-01-23 Discussion: Onsite
Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV
Letko, M. C., Munster, V.
10.1101/2020.01.22.915660 — Posted: 2020-01-22 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).